Kerstin W Sinkevicius
7PUBLICATIONS
121CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 06, 2026
Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants.Carlos Stahlhut, Anna E Maciag, Kyle A Sullivan
|Jun 12, 2025
BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interaction.Dhirendra K Simanshu, Rui Xu, James P Stice
|Dec 06, 2024
Discovery of BBO-8520, a First-In-Class Direct and Covalent Dual Inhibitor of GTP-Bound (ON) and GDP-Bound (OFF) KRASG12C.Anna E Maciag, James P Stice, Bin Wang
|Oct 15, 2024
The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Tumors.Louise Cadzow, Jehrod Brenneman, Erica Tobin
|May 05, 2022
Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody-drug Conjugate Targeting ADAM9-expressing Tumors.Juniper A Scribner, Stuart W Hicks, Kerstin W Sinkevicius
|Aug 31, 2018
ENPP1 enzyme replacement therapy improves blood pressure and cardiovascular function in a mouse model of generalized arterial calcification of infancy.Tayeba Khan, Kerstin W Sinkevicius, Sylvia Vong
Pageof 2
Frequent Collaborators
3 joint publications
Bin Wang
3 joint publications
Andrew G Stephen
3 joint publications
Ken Lin
3 joint publications
Felice C Lightstone
3 joint publications
Dana Rabara
3 joint publications
Yue Yang
3 joint publications
James P Stice
3 joint publications
Rui Xu
3 joint publications
David M Turner
3 joint publications
Erik K Larsen
